Report Detail
Global Amifostine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM2880237 |
- 17 April, 2023 |
- Global |
- 108 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
According to our (Global Info Research) latest study, the global Amifostine market size was valued at USD 51 million in 2022 and is forecast to a readjusted size of USD 59 million by 2029 with a CAGR of 2.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
This report is a detailed and comprehensive analysis for global Amifostine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Amifostine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Amifostine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Amifostine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Amifostine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Amifostine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Amifostine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical and Luye Pharma and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Amifostine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
400mg/Dose
500mg/Dose
Market segment by Application
Head and Neck Cancer Adjuvant Therapy
Others
Major players covered
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amifostine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Amifostine, with price, sales, revenue and global market share of Amifostine from 2018 to 2023.
Chapter 3, the Amifostine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amifostine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Amifostine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Amifostine.
Chapter 14 and 15, to describe Amifostine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Amifostine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Amifostine Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 400mg/Dose
- 1.3.3 500mg/Dose
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Amifostine Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Head and Neck Cancer Adjuvant Therapy
- 1.4.3 Others
- 1.5 Global Amifostine Market Size & Forecast
- 1.5.1 Global Amifostine Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Amifostine Sales Quantity (2018-2029)
- 1.5.3 Global Amifostine Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Clinigen
- 2.1.1 Clinigen Details
- 2.1.2 Clinigen Major Business
- 2.1.3 Clinigen Amifostine Product and Services
- 2.1.4 Clinigen Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Clinigen Recent Developments/Updates
- 2.2 Sun Pharmaceutical
- 2.2.1 Sun Pharmaceutical Details
- 2.2.2 Sun Pharmaceutical Major Business
- 2.2.3 Sun Pharmaceutical Amifostine Product and Services
- 2.2.4 Sun Pharmaceutical Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Sun Pharmaceutical Recent Developments/Updates
- 2.3 Taj Pharmaceuticals
- 2.3.1 Taj Pharmaceuticals Details
- 2.3.2 Taj Pharmaceuticals Major Business
- 2.3.3 Taj Pharmaceuticals Amifostine Product and Services
- 2.3.4 Taj Pharmaceuticals Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Taj Pharmaceuticals Recent Developments/Updates
- 2.4 Merro Pharmaceutical
- 2.4.1 Merro Pharmaceutical Details
- 2.4.2 Merro Pharmaceutical Major Business
- 2.4.3 Merro Pharmaceutical Amifostine Product and Services
- 2.4.4 Merro Pharmaceutical Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Merro Pharmaceutical Recent Developments/Updates
- 2.5 Luye Pharma
- 2.5.1 Luye Pharma Details
- 2.5.2 Luye Pharma Major Business
- 2.5.3 Luye Pharma Amifostine Product and Services
- 2.5.4 Luye Pharma Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Luye Pharma Recent Developments/Updates
- 2.6 Mingren Pharma
- 2.6.1 Mingren Pharma Details
- 2.6.2 Mingren Pharma Major Business
- 2.6.3 Mingren Pharma Amifostine Product and Services
- 2.6.4 Mingren Pharma Amifostine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Mingren Pharma Recent Developments/Updates
3 Competitive Environment: Amifostine by Manufacturer
- 3.1 Global Amifostine Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Amifostine Revenue by Manufacturer (2018-2023)
- 3.3 Global Amifostine Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Amifostine by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Amifostine Manufacturer Market Share in 2022
- 3.4.2 Top 6 Amifostine Manufacturer Market Share in 2022
- 3.5 Amifostine Market: Overall Company Footprint Analysis
- 3.5.1 Amifostine Market: Region Footprint
- 3.5.2 Amifostine Market: Company Product Type Footprint
- 3.5.3 Amifostine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Amifostine Market Size by Region
- 4.1.1 Global Amifostine Sales Quantity by Region (2018-2029)
- 4.1.2 Global Amifostine Consumption Value by Region (2018-2029)
- 4.1.3 Global Amifostine Average Price by Region (2018-2029)
- 4.2 North America Amifostine Consumption Value (2018-2029)
- 4.3 Europe Amifostine Consumption Value (2018-2029)
- 4.4 Asia-Pacific Amifostine Consumption Value (2018-2029)
- 4.5 South America Amifostine Consumption Value (2018-2029)
- 4.6 Middle East and Africa Amifostine Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Amifostine Sales Quantity by Type (2018-2029)
- 5.2 Global Amifostine Consumption Value by Type (2018-2029)
- 5.3 Global Amifostine Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Amifostine Sales Quantity by Application (2018-2029)
- 6.2 Global Amifostine Consumption Value by Application (2018-2029)
- 6.3 Global Amifostine Average Price by Application (2018-2029)
7 North America
- 7.1 North America Amifostine Sales Quantity by Type (2018-2029)
- 7.2 North America Amifostine Sales Quantity by Application (2018-2029)
- 7.3 North America Amifostine Market Size by Country
- 7.3.1 North America Amifostine Sales Quantity by Country (2018-2029)
- 7.3.2 North America Amifostine Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Amifostine Sales Quantity by Type (2018-2029)
- 8.2 Europe Amifostine Sales Quantity by Application (2018-2029)
- 8.3 Europe Amifostine Market Size by Country
- 8.3.1 Europe Amifostine Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Amifostine Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Amifostine Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Amifostine Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Amifostine Market Size by Region
- 9.3.1 Asia-Pacific Amifostine Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Amifostine Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Amifostine Sales Quantity by Type (2018-2029)
- 10.2 South America Amifostine Sales Quantity by Application (2018-2029)
- 10.3 South America Amifostine Market Size by Country
- 10.3.1 South America Amifostine Sales Quantity by Country (2018-2029)
- 10.3.2 South America Amifostine Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Amifostine Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Amifostine Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Amifostine Market Size by Country
- 11.3.1 Middle East & Africa Amifostine Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Amifostine Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Amifostine Market Drivers
- 12.2 Amifostine Market Restraints
- 12.3 Amifostine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Amifostine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Amifostine
- 13.3 Amifostine Production Process
- 13.4 Amifostine Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Amifostine Typical Distributors
- 14.3 Amifostine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Amifostine . Industry analysis & Market Report on Amifostine is a syndicated market report, published as Global Amifostine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Amifostine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
